Back to News
Market Impact: 0.18

Here's Why Epam (EPAM) is a Strong Value Stock

Source: zacks.com

Company FundamentalsAnalyst EstimatesAnalyst InsightsTechnology & Innovation
Here's Why Epam (EPAM) is a Strong Value Stock

EPAM Systems is highlighted as a value opportunity, trading at a forward P/E of 8.6 with a Zacks Value Score of A and VGM Score of B, although its overall Zacks Rank remains #3 (Hold). Ten analysts raised fiscal 2026 EPS estimates over the past 60 days, lifting the consensus forecast by $0.08 to $13.16 per share. EPAM's average earnings surprise is +4.2%, supporting a mildly constructive fundamental outlook.

Analysis

The relevant signal is not the promotional valuation screen but the direction and durability of EPAM's estimate revisions. A modest upward move in 2026 EPS expectations can support a near-term rerating if it reflects renewed client project starts and utilization recovery; it is not, by itself, evidence that the prior multi-year growth algorithm has normalized. At a low earnings multiple, the market is likely discounting either structurally lower offshore-engineering demand, elevated bench costs, or AI-driven pricing pressure—making quarterly revenue growth, billable utilization, and gross-margin progression more important than the headline P/E.

Over the next 1-3 months, EPAM can outperform IT-services peers if management commentary confirms discretionary spending recovery in financial services, travel, and software clients. The cleaner relative expression is versus Globant (GLOB): both are exposed to digital transformation, but EPAM has more valuation torque if demand stabilizes, while GLOB carries a richer expectation set. Over 6-18 months, generative AI is two-sided: it can create modernization work and increase engineering throughput, but also reduce billable hours and accelerate procurement pressure unless EPAM converts productivity into higher-value managed-service revenue.

Contrarian view: low-multiple IT services often remain cheap because earnings estimates lag operational deterioration. The limited magnitude of revisions and neutral-style ranking imply this is not yet a broad analyst capitulation/recovery signal. A sustained recovery thesis is falsified by another quarter of organic revenue decline, utilization failing to improve sequentially, or FY2026 EPS consensus rolling back below the recent revision trend; in that case, the apparent value multiple could be a value trap rather than a catalyst.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.28

Ticker Sentiment

EPAM0.58
NNOX0.05

Key Decisions for Investors

  • Place EPAM on a 1-3 month long watchlist rather than initiate on the article alone; enter only after the next earnings release shows sequential utilization and gross-margin improvement alongside maintained or raised FY2026 guidance. Target a 15-20% rerating on evidence of normalized growth; exit if revenue guidance is cut or FY2026 consensus begins declining.
  • For a market-neutral recovery expression, consider long EPAM / short GLOB in equal beta-adjusted dollars after EPAM confirms operating stabilization. The trade captures EPAM's lower-expectation valuation torque while limiting broad IT-services and enterprise-spending beta; close if GLOB's growth premium is validated by materially stronger bookings or EPAM misses its margin recovery milestones.
  • Do not use NNOX as a read-through or paired position: its inclusion is promotional and has no economic linkage to EPAM's engineering-services demand. Maintain separate diligence focused on NNOX regulatory, commercialization, and liquidity risks.
  • Monitor quarterly client concentration, geographic delivery mix, headcount versus revenue, and AI-related pricing disclosures. A revenue-per-employee decline without offsetting margin expansion is the key early warning that AI is commoditizing EPAM's legacy delivery model.

More News

From AllMind Research

Browse all research